Biosimulation Market Report: Trends, Forecast and Competitive Analysis to 2030

Biosimulation Trends and Forecast

The future of the global biosimulation market looks promising with opportunities in the pharmaceutical & biotechnology company, CROs, regulatory authority, and academic research Institution markets. The global biosimulation market is expected to reach an estimated $6.8 billion by 2030 with a CAGR of 13.5% from 2024 to 2030. The major drivers for this market are expanding markets for biosimilars and biologics, increasing number of regulatory organizations using biosimulation software, and growing R&D expenditures in the biotechnology and pharmaceutical sectors.

A more than 150-page report is developed to help in your business decisions.

Biosimulation by Segment

The study includes a forecast for the global biosimulation by delivery model, product, application, end use, and region.

Biosimulation Market by Delivery Model [Shipment Analysis by Value from 2018 to 2030]:

• Subscription Models
• Ownership Models

Biosimulation Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Software
• Services

Biosimulation Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Drug Development
• Drug Discovery
• Others

Biosimulation Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Pharmaceutical & Biotechnology Companies
• CROs
• Regulatory Authorities
• Academic Research Institutions

Biosimulation Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Biosimulation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities aCROss the value chain. With these strategies biosimulation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biosimulation companies profiled in this report include-

• Certara
• Dassault
• Advanced Chemistry Development
• Simulation
• Schrodinger
• Chemical Computing Group
• Physiomics
• Rosa & Co
• BioSimulation Consulting
• Genedata

Biosimulation Market Insights

Lucintel forecasts that drug development will remain the larger segment over the forecast period due to the growing number of government efforts encouraging the use of sophisticated software.

North America will remain the largest region over the forecast period due to the existence of key players, increased healthcare digitalization, and the rising prevalence of chronic health concerns.

Features of the Global Biosimulation Market

Market Size Estimates: Biosimulation market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biosimulation market size by various segments, such as by delivery model, product, application, end use, and region in terms of value ($B).

Regional Analysis: Biosimulation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different delivery model, product, application, end use, and regions for the biosimulation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biosimulation market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the biosimulation market size?

Answer: The global biosimulation market is expected to reach an estimated $6.8 billion by 2030.

Q2. What is the growth forecast for biosimulation market?

Answer: The global biosimulation market is expected to grow with a CAGR of 13.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the biosimulation market?

Answer: The major drivers for this market are expanding markets for biosimilars and biologics, increasing number of regulatory organizations using biosimulation software and increasing r&d expenditures in the biotechnology and pharmaceutical sectors.

Q4. What are the major segments for biosimulation market?

Answer: The future of the biosimulation market looks promising with opportunities in the pharmaceutical & biotechnology company, CROs, regulatory authority, and academic research institution markets.

Q5. Who are the key biosimulation market companies?

Answer: Some of the key biosimulation companies are as follows.

• Certara
• Dassault
• Advanced Chemistry Development
• Simulation
• Schrodinger
• Chemical Computing Group
• Physiomics
• Rosa & Co
• BioSimulation Consulting
• Genedata

Q6. Which biosimulation market segment will be the largest in future?

Answer: Lucintel forecasts that drug development will remain the larger segment over the forecast period due to the growing number of government efforts encouraging the use of sophisticated software.

Q7. In biosimulation market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the existence of key players, increased healthcare digitalization, and the rising prevalence of chronic health concerns.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the biosimulation market by delivery model (subscription models and ownership models), product (software and services), application (drug development, drug discovery, and others), end use (pharmaceutical & biotechnology companies, CROs, regulatory authorities, and academic research institutions), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?